Published in J Med Genet on December 01, 2007
De novo copy number variants identify new genes and loci in isolated sporadic tetralogy of Fallot. Nat Genet (2009) 3.86
Contribution of global rare copy-number variants to the risk of sporadic congenital heart disease. Am J Hum Genet (2012) 1.92
Rare copy number variations in congenital heart disease patients identify unique genes in left-right patterning. Proc Natl Acad Sci U S A (2011) 1.71
Identification of novel candidate gene loci and increased sex chromosome aneuploidy among infants with conotruncal heart defects. Am J Med Genet A (2013) 1.48
Transcription factor pathways and congenital heart disease. Curr Top Dev Biol (2012) 1.41
Chromosome 8p23.1 deletions as a cause of complex congenital heart defects and diaphragmatic hernia. Am J Med Genet A (2009) 1.40
The pathogenesis of atrial and atrioventricular septal defects with special emphasis on the role of the dorsal mesenchymal protrusion. Differentiation (2012) 1.34
Increased frequency of de novo copy number variants in congenital heart disease by integrative analysis of single nucleotide polymorphism array and exome sequence data. Circ Res (2014) 1.32
Interaction of Gata4 and Gata6 with Tbx5 is critical for normal cardiac development. Dev Biol (2008) 1.29
Loss of Gata5 in mice leads to bicuspid aortic valve. J Clin Invest (2011) 1.28
The contribution of de novo and rare inherited copy number changes to congenital heart disease in an unselected sample of children with conotruncal defects or hypoplastic left heart disease. Hum Genet (2013) 1.15
Mammalian sex determination—insights from humans and mice. Chromosome Res (2012) 1.14
Identification of GATA6 sequence variants in patients with congenital heart defects. Pediatr Res (2010) 1.10
Of mice and men: molecular genetics of congenital heart disease. Cell Mol Life Sci (2013) 1.10
Stem cell models of cardiac development and disease. Annu Rev Cell Dev Biol (2010) 1.03
Congenital heart disease-causing Gata4 mutation displays functional deficits in vivo. PLoS Genet (2012) 1.03
An excess of deleterious variants in VEGF-A pathway genes in Down-syndrome-associated atrioventricular septal defects. Am J Hum Genet (2012) 1.01
Molecular genetics of congenital atrial septal defects. Clin Res Cardiol (2009) 0.99
Disruption of aryl hydrocarbon receptor homeostatic levels during embryonic stem cell differentiation alters expression of homeobox transcription factors that control cardiomyogenesis. Environ Health Perspect (2013) 0.97
A variant in the carboxyl-terminus of connexin 40 alters GAP junctions and increases risk for tetralogy of Fallot. Eur J Hum Genet (2012) 0.94
Mutations of the GATA4 and NKX2.5 genes in Chinese pediatric patients with non-familial congenital heart disease. Genetica (2010) 0.94
Combined mutation screening of NKX2-5, GATA4, and TBX5 in congenital heart disease: multiple heterozygosity and novel mutations. Congenit Heart Dis (2011) 0.92
Loss-of-function mutation in GATA4 causes anomalies of human testicular development. Proc Natl Acad Sci U S A (2011) 0.92
A novel GATA4 loss-of-function mutation associated with congenital ventricular septal defect. Pediatr Cardiol (2011) 0.91
Identification of functional mutations in GATA4 in patients with congenital heart disease. PLoS One (2013) 0.91
8p23.1 duplication syndrome differentiated from copy number variation of the defensin cluster at prenatal diagnosis in four new families. Mol Cytogenet (2010) 0.90
New Genetic Insights into Congenital Heart Disease. J Clin Exp Cardiolog (2012) 0.89
The transcription factor Atonal homolog 8 regulates Gata4 and Friend of Gata-2 during vertebrate development. J Biol Chem (2013) 0.88
GATA4 mutations in Chinese patients with congenital cardiac septal defects. Pediatr Cardiol (2009) 0.87
Congenital heart disease: the crossroads of genetics, epigenetics and environment. Curr Genomics (2014) 0.85
GATA5 loss-of-function mutation responsible for the congenital ventriculoseptal defect. Pediatr Cardiol (2012) 0.84
A Rapid, High-Quality, Cost-Effective, Comprehensive and Expandable Targeted Next-Generation Sequencing Assay for Inherited Heart Diseases. Circ Res (2015) 0.84
GATA5 loss-of-function mutations underlie tetralogy of fallot. Int J Med Sci (2012) 0.82
Impact of Mendelian inheritance in cardiovascular disease. Ann N Y Acad Sci (2010) 0.80
Novel GATA4 mutations in patients with congenital ventricular septal defects. Med Sci Monit (2012) 0.80
Mutation spectrum of GATA4 associated with congenital atrial septal defects. Arch Med Sci (2013) 0.80
GATA5 mutation homozygosity linked to a double outlet right ventricle phenotype in a Lebanese patient. Mol Genet Genomic Med (2015) 0.78
Mutations in NTRK3 suggest a novel signaling pathway in human congenital heart disease. Hum Mutat (2014) 0.78
A study of the role of GATA4 polymorphism in cardiovascular metabolic disorders. Hum Genomics (2013) 0.77
c.620C>T mutation in GATA4 is associated with congenital heart disease in South India. BMC Med Genet (2015) 0.77
Increased Hemodynamic Load in Early Embryonic Stages Alters Endocardial to Mesenchymal Transition. Front Physiol (2017) 0.77
Insights into the genetic structure of congenital heart disease from human and murine studies on monogenic disorders. Cold Spring Harb Perspect Med (2014) 0.77
Germline mutations in NKX2-5, GATA4, and CRELD1 are rare in a Mexican sample of Down syndrome patients with endocardial cushion and septal heart defects. Pediatr Cardiol (2014) 0.76
Genetics of Congenital Heart Defects: The NKX2-5 Gene, a Key Player. Genes (Basel) (2016) 0.76
Mutational screening of affected cardiac tissues and peripheral blood cells identified novel somatic mutations in GATA4 in patients with ventricular septal defect. J Biomed Res (2011) 0.76
Tetralogy of Fallot and Hypoplastic Left Heart Syndrome - Complex Clinical Phenotypes Meet Complex Genetic Networks. Curr Genomics (2015) 0.76
We need a detailed phenome in the phenomenon of genetics and congenital heart disease. J Med Genet (2008) 0.75
Rare copy number variants in patients with congenital conotruncal heart defects. Birth Defects Res (2017) 0.75
Mutation Screening of Gata4 Gene in CTD Patients Within Chinese Han Population. Pediatr Cardiol (2017) 0.75
SIFT: Predicting amino acid changes that affect protein function. Nucleic Acids Res (2003) 52.26
Predicting deleterious amino acid substitutions. Genome Res (2001) 28.95
Prediction of deleterious human alleles. Hum Mol Genet (2001) 21.00
Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat Rev Genet (2002) 16.29
A "silent" polymorphism in the MDR1 gene changes substrate specificity. Science (2006) 15.18
ESEfinder: A web resource to identify exonic splicing enhancers. Nucleic Acids Res (2003) 12.81
A genomic view of alternative splicing. Nat Genet (2002) 12.62
GATA4 mutations cause human congenital heart defects and reveal an interaction with TBX5. Nature (2003) 6.40
Alternative splicing in the human, mouse and rat genomes is associated with an increased frequency of exon creation and/or loss. Nat Genet (2003) 6.09
Congenital heart disease caused by mutations in the transcription factor NKX2-5. Science (1998) 5.98
Towards a structural basis of human non-synonymous single nucleotide polymorphisms. Trends Genet (2000) 5.41
Congenital heart disease: prevalence at livebirth. The Baltimore-Washington Infant Study. Am J Epidemiol (1985) 4.78
Frequency of 22q11 deletions in patients with conotruncal defects. J Am Coll Cardiol (1998) 3.86
A genetic blueprint for cardiac development. Nature (2000) 3.45
Mutations in the cardiac transcription factor NKX2.5 affect diverse cardiac developmental pathways. J Clin Invest (1999) 2.95
Subnuclear localization of WT1 in splicing or transcription factor domains is regulated by alternative splicing. Cell (1995) 2.63
A threshold of GATA4 and GATA6 expression is required for cardiovascular development. Proc Natl Acad Sci U S A (2006) 2.32
GATA4 is a dosage-sensitive regulator of cardiac morphogenesis. Dev Biol (2004) 2.13
NKX2.5 mutations in patients with congenital heart disease. J Am Coll Cardiol (2003) 2.09
NKX2.5 mutations in patients with tetralogy of fallot. Circulation (2001) 1.96
Phenotypes with GATA4 or NKX2.5 mutations in familial atrial septal defect. Am J Med Genet A (2005) 1.69
A novel mutation in the GATA4 gene in patients with Tetralogy of Fallot. Hum Mutat (2006) 1.64
GATA4 haploinsufficiency in patients with interstitial deletion of chromosome region 8p23.1 and congenital heart disease. Am J Med Genet (1999) 1.59
The genetics of Wilms' tumor--a case of disrupted development. Annu Rev Genet (1994) 1.58
Detection of single-nucleotide polymorphisms with the WAVE DNA fragment analysis system. Genet Test (1999) 1.57
Delineation of the critical deletion region for congenital heart defects, on chromosome 8p23.1. Am J Hum Genet (1999) 1.56
Genetics. SNPs, silent but not invisible. Science (2006) 1.50
Seemingly neutral polymorphic variants may confer immunity to splicing-inactivating mutations: a synonymous SNP in exon 5 of MCAD protects from deleterious mutations in a flanking exonic splicing enhancer. Am J Hum Genet (2007) 1.50
Spectrum of atrial septal defects associated with mutations of NKX2.5 and GATA4 transcription factors. J Med Genet (2005) 1.43
A novel GATA4 mutation completely segregated with atrial septal defect in a large Japanese family. J Med Genet (2004) 1.37
Deletion of a 5-cM region at chromosome 8p23 is associated with a spectrum of congenital heart defects. Circulation (2000) 1.32
Screening and biochemical analysis of GATA4 sequence variations identified in patients with congenital heart disease. Am J Med Genet A (2007) 1.13
Recurrence risks in children having one parent with a congenital heart disease. Circulation (1976) 1.07
Ligand-activated Ahr signaling leads to disruption of nephrogenesis and altered Wilms' tumor suppressor mRNA splicing. Oncogene (2003) 0.98
Polymorphisms of genes of the cardiac calcineurin pathway and cardiac hypertrophy. Eur J Hum Genet (2003) 0.86
Marfan syndrome caused by a recurrent de novo missense mutation in the fibrillin gene. Nature (1991) 11.44
Comparison of four basic models of indirect pharmacodynamic responses. J Pharmacokinet Biopharm (1993) 3.96
Trial of calcium to prevent preeclampsia. N Engl J Med (1997) 3.69
Features of Alagille syndrome in 92 patients: frequency and relation to prognosis. Hepatology (1999) 2.91
Eosinophilic oesophagitis: a novel treatment using Montelukast. Gut (2003) 2.64
The Philadelphia story: the 22q11.2 deletion: report on 250 patients. Genet Couns (1999) 2.58
Blood pressure and nutrient intake in the United States. Science (1984) 2.33
A population-based prospective evaluation of risk of sudden cardiac death after operation for common congenital heart defects. J Am Coll Cardiol (1998) 2.02
Lazarine leprosy--revisited? Indian J Lepr (2005) 2.02
Pregnancy outcomes in healthy nulliparas who developed hypertension. Calcium for Preeclampsia Prevention Study Group. Obstet Gynecol (2000) 1.99
Association of chromosome 22q11 deletion with isolated anomalies of aortic arch laterality and branching. J Am Coll Cardiol (2001) 1.75
Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem (1997) 1.73
Cognitive and behavior profile of preschool children with chromosome 22q11.2 deletion. Am J Med Genet (1999) 1.71
Marfan phenotype variability in a family segregating a missense mutation in the epidermal growth factor-like motif of the fibrillin gene. J Clin Invest (1992) 1.68
Localization of the fibrillin (FBN) gene to chromosome 15, band q21.1. Genomics (1991) 1.67
Accuracy of self-reported cigarette smoking among pregnant women in the 1990s. Paediatr Perinat Epidemiol (2001) 1.61
A randomized trial of improved weight loss with a prepared meal plan in overweight and obese patients: impact on cardiovascular risk reduction. Arch Intern Med (2000) 1.58
Dietary compliance and cardiovascular risk reduction with a prepared meal plan compared with a self-selected diet. Am J Clin Nutr (1997) 1.57
Serum alkaline phosphatase reflects post-Fontan hemodynamics in children. Pediatr Cardiol (2008) 1.56
Impact of increasing calcium in the diet on nutrient consumption, plasma lipids, and lipoproteins in humans. Am J Clin Nutr (1994) 1.47
A molecular pathway revealing a genetic basis for human cardiac and craniofacial defects. Science (1999) 1.44
Perinatal ovarian cyst: a nonsurgical approach. J Pediatr Surg (1992) 1.38
Rare structural variation of synapse and neurotransmission genes in autism. Mol Psychiatry (2011) 1.36
The 22q11.2 deletion: screening, diagnostic workup, and outcome of results; report on 181 patients. Genet Test (1997) 1.33
Upregulation of the oncogene c-myc in Barrett's adenocarcinoma: induction of c-myc by acidified bile acid in vitro. Gut (2003) 1.32
Carrier frequency of the common mutation IVS8-1G>C in DHCR7 and estimate of the expected incidence of Smith-Lemli-Opitz syndrome. Mol Genet Metab (2001) 1.28
Mutation analysis of TBX1 in non-deleted patients with features of DGS/VCFS or isolated cardiovascular defects. J Med Genet (2001) 1.24
Pulmonary tuberculosis in the elderly: a different disease? Thorax (1990) 1.21
An overview of remote sensing and GIS for surveillance of mosquito vector habitats and risk assessment. J Vector Ecol (1998) 1.13
Dietary calcium in human hypertension. Science (1982) 1.13
Translational careers. Science (2009) 1.13
Multicenter randomized trial of a comprehensive prepared meal program in type 2 diabetes. Diabetes Care (1999) 1.12
Epidemiology of syncope in hospitalized patients. J Gen Intern Med (1999) 1.09
Predictors of outcome in thymectomy for myasthenia gravis. Ann Thorac Surg (2001) 1.08
Trial of Calcium for Preeclampsia Prevention (CPEP): rationale, design, and methods. Control Clin Trials (1996) 1.07
Loss-of-function mutations in growth differentiation factor-1 (GDF1) are associated with congenital heart defects in humans. Am J Hum Genet (2007) 1.06
Patterns of right aortic arch and mirror-image branching of the brachiocephalic vessels without associated anomalies. Pediatr Cardiol (2001) 1.05
Regional localization of over 300 loci on human chromosome 22 using a somatic cell hybrid mapping panel. Genomics (1996) 1.05
Jagged1 mutations in patients ascertained with isolated congenital heart defects. Am J Med Genet (1999) 1.03
The expression of anger and its consequences. Behav Res Ther (1996) 1.02
A simplified, competitive RT-PCR method for measuring rat IFN-gamma mRNA expression. J Immunol Methods (1996) 1.00
Arboviruses associated with mosquitoes from nine Florida counties during 1993. J Am Mosq Control Assoc (1996) 0.99
Chromosome 22q11 deletion in patients with truncus arteriosus. Pediatr Cardiol (2003) 0.98
Comparison of patterns of pulmonary venous blood flow in the functional single ventricle heart after operative aortopulmonary shunt versus superior cavopulmonary shunt. Am J Cardiol (1997) 0.97
Epizootiology of eastern equine encephalomyelitis virus in upstate New York, USA. I. Introduction, demography and natural environment of an endemic focus. J Med Entomol (1980) 0.96
Blood pressure response to oral calcium in persons with mild to moderate hypertension. A randomized, double-blind, placebo-controlled, crossover trial. Ann Intern Med (1985) 0.95
Angiotensin-converting enzyme and cardiovascular disease risk. Curr Opin Lipidol (1999) 0.95
Epizootiology of eastern equine encephalomyelitis virus in upstate New York, USA. II. Population dynamics and vector potential of adult Culiseta melanura (Diptera: Culicidae) in relation to distance from breeding site. J Med Entomol (1980) 0.95
Is Down syndrome a risk factor for poor outcome after repair of congenital heart defects? J Pediatr (1998) 0.93
Epizootiology of eastern equine encephalitis virus in upstate New York, USA. VII. Virus surveillance 1978-85, description of 1983 outbreak, and series conclusions. J Med Entomol (1988) 0.93
Ginkgo biloba for the improvement of cognitive performance in multiple sclerosis: a randomized, placebo-controlled trial. Mult Scler (2007) 0.92
Eastern equine encephalomyelitis in upstate New York 1972-1974. Am J Trop Med Hyg (1975) 0.92
Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion. Cardiovasc Res (2000) 0.92
Sensitive and specific colorimetric dot assay to detect eastern equine encephalomyelitis viral RNA in mosquitoes (Diptera: Culicidae) after polymerase chain reaction amplification. J Med Entomol (1995) 0.92
Ethnicity, nutrition, and birth outcomes in nulliparous women. Am J Obstet Gynecol (2001) 0.92
Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study. J Med Genet (2005) 0.92
Nutritionally complete prepared meal plan to reduce cardiovascular risk factors: a randomized clinical trial. J Am Diet Assoc (1999) 0.91
Transmission of Lacrosse virus (California encephalitis group) by the mosquito Aedes triseriatus. J Med Entomol (1972) 0.91
Nutritional management of cardiovascular risk factors. A randomized clinical trial. Arch Intern Med (1997) 0.90
A crossover study of gabapentin in treatment of restless legs syndrome among hemodialysis patients. Am J Kidney Dis (2001) 0.90
Enhanced oxidative metabolism of neutrophils from patients with systemic sclerosis. Br J Rheumatol (1987) 0.90
Cardiovascular anomalies in patients diagnosed with a chromosome 22q11 deletion beyond 6 months of age. Pediatrics (2001) 0.89
Reproducibility of arrhythmia induction with intracardiac electrophysiologic testing: patients with clinical sustained ventricular tachyarrhythmias. J Am Coll Cardiol (1986) 0.89
DiGeorge anomaly with renal agenesis in infants of mothers with diabetes. Am J Med Genet (1993) 0.88
The calcium paradox of essential hypertension. Am J Med (1987) 0.88
Angiotensin-converting enzyme DD genotype and cardiovascular disease in heterozygous familial hypercholesterolemia. Circulation (1998) 0.87
Blood pressure and metabolic responses to moderate sodium restriction in isradipine-treated hypertensive patients. Am J Hypertens (1997) 0.87
Epizootiology of eastern equine encephalomyelitis virus in upstate New York, USA. VI. Antibody prevalence in wild birds during an interepizootic period. J Med Entomol (1984) 0.86
Evaluation of public information packets for mosquito source reduction in two Florida cities. J Am Mosq Control Assoc (1995) 0.86
Osteoporosis in postmenopausal women: diagnosis and monitoring. Evid Rep Technol Assess (Summ) (2001) 0.85
Effect of diet and weight reduction in hypertension. Nutrition (1992) 0.85
Dietary calcium and blood pressure: modifying factors in specific populations. Am J Clin Nutr (1991) 0.85
Culex annulirostris breeding sites in urban areas: using remote sensing and digital image analysis to develop a rapid predictor of potential breeding areas. J Am Mosq Control Assoc (1996) 0.85
An evaluation of the hypothesis of transovarial transmission of eastern equine encephalomyelitis virus by Culiseta melanura. Am J Trop Med Hyg (1978) 0.85
Epizootiology of eastern equine encephalomyelitis virus in upstate New York, USA. V. Habitat preference of host-seeking mosquitoes (Diptera: Culicidae). J Med Entomol (1983) 0.85
The oxidation of serum sulph-hydryl groups by hydrogen peroxide secreted by stimulated phagocytic cells in rheumatoid arthritis. Rheumatol Int (1984) 0.84
PTPN11 mutations play a minor role in isolated congenital heart disease. Am J Med Genet A (2005) 0.84
Detection of a 22q11.2 deletion in cardiac patients suggests a risk for velopharyngeal incompetence. Pediatrics (1997) 0.84
Bionomics of anthropophilic Simuliidae (Diptera) from the Adirondack Mountains of New York State, USA. 1. Adult dispersal and longevity. J Med Entomol (1985) 0.83
Phenology of trophic amd gonobiologic states in Culiseta morsitans and Culiseta melanura (Diptera: Culicidae). J Med Entomol (1984) 0.83
Hypertension and calcium. Science (1984) 0.83
Isolation of Jamestown Canyon serotype of California encephalitis virus from naturally infected Aedes mosquitoes and tabanids. Am J Trop Med Hyg (1969) 0.83
All-blood (miniplegia) versus dilute cardioplegia in experimental surgical revascularization of evolving infarction. Circulation (2001) 0.83
Parity, fecundity and body size of Mansonia dyari in Florida. J Am Mosq Control Assoc (1990) 0.83
Increased dietary micronutrients decrease serum homocysteine concentrations in patients at high risk of cardiovascular disease. Am J Clin Nutr (1999) 0.83
Epizootiology of eastern equine encephalomyelitis virus in upstate New York, USA. III. Population dynamics and vector potential of adult Culiseta morsitans (Diptera: Culicidae). J Med Entomol (1981) 0.83
Evaluation of 1-octen-3-ol as an attractant for Coquillettidia perturbans, Mansonia spp. and Culex spp. associated with phosphate mining operations. J Am Mosq Control Assoc (1990) 0.82
An observational analysis of erythromelanosis follicularis faciei et colli. Clin Exp Dermatol (2008) 0.82
Decreased calcium pump adenosine triphosphatase in red blood cells of hypertensive subjects. Hypertension (1986) 0.82
Urinary calcium excretion in essential hypertension. J Lab Clin Med (1992) 0.81
Should the definition of preeclampsia include a rise in diastolic blood pressure of >/=15 mm Hg to a level <90 mm Hg in association with proteinuria? Am J Obstet Gynecol (2000) 0.81
A BamHI polymorphism at the fibrillin (FBN) locus. Nucleic Acids Res (1991) 0.81
Pharmacodynamic modeling of nonsteroidal anti-inflammatory drugs: antipyretic effect of ibuprofen. Clin Pharmacol Ther (1994) 0.81
An outbreak of Eastern equine encephalomyelitis in Upstate New York during 1971. Am J Trop Med Hyg (1973) 0.81
Calcium binding, hydroxylation, and glycosylation of the precursor epidermal growth factor-like domains of fibrillin-1, the Marfan gene protein. J Biol Chem (1994) 0.80
Plasma lipids and hypertension: response to calcium supplementation. Am J Clin Nutr (1987) 0.80
Who defines Barrett's oesophagus: endoscopist or pathologist? Eur J Gastroenterol Hepatol (2001) 0.80
Blood pressure and calcium intake are related to bone density in adult males. Br J Nutr (1999) 0.80
Observations on the effect of glass beads on platelet aggregation and its relation to platelet stickiness. Thromb Diath Haemorrh (1968) 0.80